Meet Dr. Stephen Withrow

FACC home

clinical team

clinical trials

treatment options

about cancer

ways to give

saying goodbye

CSU pet hospice

emotional support

related links

join our mailing list
join our mailing list
events calendar

There are no events to display for this time period.

Follow us on Facebook Veterinary Teaching Hospital
CSU Campaign
Advancing Cancer Treatment
| Share

Clinical Trials

Varian Linear AcceleratorThe Flint Animal Cancer Center at Colorado State University has many ongoing clinical trials. These studies help doctors in the medical and veterinary fields investigate methods to improve detection and treatment of cancer, as well as improve the quality of care each patient receives.

We understand that hearing a diagnosis of cancer in a loved one can be very emotional. We know it can be confusing and difficult to understand some of the medical terminology. For some, even entering a veterinary hospital may seem overwhelming. For this reason, the Flint Animal Cancer Center has assembled a special team to help people understand the language and requirements of clinical research trials. And most importantly, the team will provide familiar faces and offer gentle encouragement to the entire family. Our goal is to give you a thorough understanding of our clinical trials, explain what is in store for you and your pet, and provide compassionate care throughout the treatment period.

Below you will find a thumbnail sketch of several of the clinical trials for which we are accepting patients. The studies are listed in no particular order. Described for each clinical trial is the purpose of the study, the patient entry criteria, the responsibilities of the pet owners, and any financial incentives that may apply. In general, these studies are available to qualifying patients living within 100 miles of the Flint Animal Cancer Center at Colorado State University. If you have further questions about any of our clinical trials, please either login or sign up to submit a consulting form or call our Oncology Clinical Coordinator at (970) 297-4068.

Online Consulting Form


Looking for the Golden Retriever Lifetime Study?

Thanks for your interest. We are a proud partner with the Morris Animal Foundation for this important research.

For more information and to learn more about possibly enrolling your Golden Retriever, please visit the
Morris Animal Foundation’s Canine Lifetime Health project.

Ongoing Clinical Trials

  Canine Osteosarcoma
    Reversal of Tumor Immune Suppression with Losartan and Toceranib for Treatment of Osteosarcoma Metastases  
    Biomarkers of Toceranib Benefit in Dogs with Pulmonary Metastatic Osteosarcoma  
    Open-Label, Phase-2 Trial of NV-01 for Pain Palliation in Dogs with Osteosarcoma  
  Canine Mast Cell Tumors
    AB1010/Masitinib Phase 3 Trial in Canine Mast Cell Tumors  
    Palladia vs. Vinblastine in Canine Mast Cell Tumors  
  Canine Lymphoma
    COTC007b: Expanded Evaluation of an Indenoisoquinoline Candidate in Dogs with Lymphoma and Soft Tissue Sarcoma  
    Efficacy of TANOVEA (Rabacfosadine for Injection) in Dogs with Lymphoma VC-008  
    Development of a Histopathologic and Flow Cytometric Subclassification System in Canine Lymphoma  
    EZN-3042 in Canine Lymphoma  
    VDC-597 for Treatment of Canine B-Cell Lymphoma  
  Canine Primary Lung Tumors
    Photodynamic Therapy for Canine Lung Tumors  
  Canine Soft Tissue Sarcoma
    Stereotactic Radiation Therapy Alters Tumor Microvasculature  
  Canine Transitional Cell Carcinoma
    Evaluation of DAB389EGF for Canine TCC of the Bladder  
  Multiple Tumor Types
    COTC020: Evaluation of Orally Administered mTOR inhibitor Rapamycin in Dogs with Osteosarcoma or Soft Tissue Sarcoma  
    Dasatinib Phase 1 Pharmacokinetics and Pharmacodynamics in Dogs  
    Sentinel Lymph Node Detection Study for any malignant tumor of the head or neck  
    Pilot, Open Label, phase-1 Study of svL4 in dogs with any tumor type  

If you have further questions about any of our clinical trials, Please either login or sign up to submit a consulting form. Your consult will then be directed to an appropriate oncology clinician. Requests are typically returned within 2 business days